Clinical Trial Update: ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of ISIS 183750 in combination with irinotecan for advanced solid tumors and colorectal cancer has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ISIS 183750
• Irinotecan (Irinotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Neoplasms, Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-04-25